Uniplan Investment Counsel, Inc. Cbd Md, Inc. Transaction History

Uniplan Investment Counsel, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.0 - $6.95 $0 - $5.16 Million	-742,488 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.0 - $7.49 $0 - $24,110	-3,219 Reduced 0.43%	742,488 $1.54 Million
Q2 2021 Aug 13, 2021	BUY	$7.46 - $9.49 $31,563 - $40,152	4,231 Added 0.57%	745,707 $2.16 Million
Q1 2021 May 14, 2021	BUY	$7.81 - $10.5 $16,947 - $22,785	2,170 Added 0.29%	741,476 $3.07 Million
Q4 2020 Feb 12, 2021	SELL	$7.36 - $9.0 $240,642 - $294,264	-32,696 Reduced 4.24%	739,306 $2.18 Million
Q3 2020 Nov 13, 2020	BUY	$7.61 - $9.0 $5.87 Million - $6.95 Million	772,002 New	772,002 $1.54 Million

125K

Ticker YCBD
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,555,600
Market Cap $21.8M
Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.